Literature DB >> 1172777

The destruction of type 2 pneumocytes by airborne influenza PR8-A virus; its effect on surfactant and lecithin content of the pneumonic lesions of mice.

C G Loosli, S F Stinson, D P Ryan, M S Hertweck, J D Hardy, R Serebrin.   

Abstract

Influenzal pneumonia has been studied in mice subjected to sublethal doses of airborne PR8-A influenza virus. Electron microscopy revealed that the virus propagated in and at the same time destroyed the ciliated and nonciliated bronchial cells and the types 1 and 2 alveolar pneumocytes. The regenerating bronchial membranes were metaplastic and grew peripherally into the surrounding alveolar ducts and alveoli to form epithelial nodules which caused obstruction and collapse of the involved lobes. The development of the lung lesions was correlated with phospholipid (lecithin) levels in consolidated and unconsolidated infected and normal lungs. As the lungs became more and more consolidated, there was a corresponding and significant decrease in the amount of phospholipid (dipalmitoyl lecithin) compared to the amount of normal or unconsolidated infected tissue. The destruction of the type 2 pneumocytes by the influenza virus and their failure to regenerate is considered to be the reason for the low phospholipid levels in the involved lobes, and thus an important cause of post-influenzal collapse in mice. The above adds additional evidence to the view that the type 2 pneumocytes are a major source of surfactant in mammalian lungs.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1172777     DOI: 10.1378/chest.67.2_supplement.7s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  30 in total

1.  Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Authors:  Dane Parker
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 2.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

3.  Adaptation of pandemic H1N1 influenza viruses in mice.

Authors:  Natalia A Ilyushina; Alexey M Khalenkov; Jon P Seiler; Heather L Forrest; Nicolai V Bovin; Henju Marjuki; Subrata Barman; Robert G Webster; Richard J Webby
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 4.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

5.  Sendai virus infection in genetically resistant and susceptible mice.

Authors:  D G Brownstein; A L Smith; E A Johnson
Journal:  Am J Pathol       Date:  1981-11       Impact factor: 4.307

6.  Infection of cultured human type II pneumonocytes with certain respiratory viruses.

Authors:  D A Tyrrell; M Mika-Johnson; G Phillips; W H Douglas; P J Chapple
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus.

Authors:  Lemme P Kebaabetswe; Anoria K Haick; Marina A Gritsenko; Thomas L Fillmore; Rosalie K Chu; Samuel O Purvine; Bobbie-Jo Webb-Robertson; Melissa M Matzke; Richard D Smith; Katrina M Waters; Thomas O Metz; Tanya A Miura
Journal:  Virology       Date:  2015-05-15       Impact factor: 3.616

8.  Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung.

Authors:  Hong D Chen; Armando E Fraire; Isabelle Joris; Raymond M Welsh; Liisa K Selin
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

9.  Lecithin changes in murine Mycoplasma pulmonis respiratory infection.

Authors:  J D Pollack; H S Weiss; N L Somerson
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

10.  Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.

Authors:  Jeffrey E Gotts; Jason Abbott; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.